Researchers have demonstrated that overexpressing TEM8 in preclinical breast cancer models resulted in the amplified capability of the tumor for expansion and metastasis whereas blocking or knocking out TEM8 expression hindered tumor progression in various preclinical models (159–162). This evidence concerns the gene ANTXR1 and breast carcinoma.